Innehållet på denna webbplats är endast avsett för veterinärer eller andra professionella inom djurhälsovård.
Genom att använda denna webbplats accepterar du ovanstående.
NOTICE OF ANNUAL GENERAL MEETING IN INTERVACC AB (PUBL)
A correction to this press release has been published, please use this link for all documents prior to the 2023 AGM. The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on...Report from Extraordinary General Meeting in Intervacc
Intervacc AB (publ) has held its Extraordinary General Meeting (”EGM”) on Friday 5 May 2023, at which a resolution on authorisation for the board of directors to resolve on rights issue of shares was made. The EGM authorised the board of directors to, in the period...Interim report January – March 2023
The period in summary Group key ratios 01/01/23 01/01/22 01/01/22 -31/03/23 -31/03/22 -31/12/22 Net sales 1 483 1 172 9 684 Operating result -17 441 -10 697 -64 413 Result after financial items -17 476 -10 726 -64 155 Cash flow from...NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL)
The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Extraordinary General Meeting (“EGM”) to be held on Friday 5 May 2023 at 10.00 a.m. at Good Morning Hotel, Västertorpsvägen 131, in Hägersten. The Board of...The Board of Directors in Intervacc intends to resolve on a fully covered rights issue of approximately SEK 100 million
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER...Nyhetstjänster
